Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
Top Cited Papers
- 1 May 2011
- journal article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 107 (9), 1375-1380
- https://doi.org/10.1016/j.amjcard.2011.01.006
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumabAmerican Heart Journal, 2009
- Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adultsClinical Research in Cardiology, 2008
- Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II studyAnti-Cancer Drugs, 2007
- Acute Cardiac Functional and Morphological Changes After Anthracycline Infusions in ChildrenThe American Journal of Cardiology, 2007
- Response and Cardiac Toxicity of Trastuzumab Given in Conjunction with Weekly Paclitaxel After Doxorubicin/CyclophosphamideClinical Breast Cancer, 2006
- Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injuryEuropean Heart Journal, 2006
- Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective studyBritish Journal of Cancer, 2006
- Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.2006
- Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31Journal of Clinical Oncology, 2005
- Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose ChemotherapyCirculation, 2004